Ionis Pharmaceuticals (IONS) PT Raised to $77 at Jefferies

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/25/2026

1. INTC
2. DECK
3. META
4. AMD
5. INFY
6. UNP
7. GOOGL
8. RNG
9. SPY
10. TMUS

Go back to Ionis Pharmaceuticals (IONS) PT Raised to $77 at Jefferies

Ionis announces positive detailed results from the HALOS Study of ION582 in people with Angelman syndrome

July 22, 2024 7:00 AM EDT

ION582 showed robust and consistent benefit in communication, cognition and motor function in a broad patient population evaluated with a comprehensive set of assessment tools that collect input from parents and clinicians97% of patients in the medium and high dose groups saw improvement in overall Angelman syndrome symptoms as measured by the SAS-CGI-C Improvements on the Bayley-4 in cognition, communication and motor function exceeded those observed in natural history studiesIonis plans to initiate Phase 3 development in H1 2025Ionis to host webcast on Monday, July 22 at... More

Ionis to hold second quarter 2024 financial results webcast

July 19, 2024 8:24 AM EDT

Webcast scheduled for Thursday, August 1 at 11:30 a.m. Eastern Time

CARLSBAD, Calif., July 19, 2024 /PRNewswire/... More

Ionis completes enrollment in pivotal trial evaluating zilganersen in people living with Alexander disease

July 18, 2024 7:00 AM EDT

Zilganersen is the first investigational medicine in clinical development for people with Alexander disease, a rare, life-threatening neurological condition

CARLSBAD, Calif., July 18, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it has completed enrollment in the pivotal trial of zilganersen... More